GNH USA

Europe — EMA

Octaplex

GNH USA supplies Octaplex (Human Coagulation Factors), a coagulation factor concentrate for hemophilia B and protein C/S deficiencies. Request a quote today.

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Human Coagulation Factor IX, Protein C, Human Coagulation Factor VII, Protein S, Human Coagulation Factor X, the active ingredient in Octaplex, is a coagulation factor concentrate presented as a sterile intravenous solution for intravenous use. It replaces deficient clotting factors in patients with bleeding disorders.

GNH USA supplies Octaplex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?

Octaplex is used to replace deficient coagulation factors in disorders of the clotting cascade.

Hemophilia B (Factor IX deficiency): provides factor IX to achieve hemostasis in bleeding episodes. Congenital protein C deficiency: supplies protein C to reduce risk of thrombosis. Congenital protein S deficiency: supplies protein S to support anticoagulant pathways. Multiple factor deficiencies (e.g., combined factor VII and X deficiency): restores missing factors to normalize clotting.

What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Common Side Effects: - Infusion‑related reactions such as fever, chills, or mild headache. - Nausea or vomiting during or shortly after administration. - Transient hypotension or mild dizziness. - Local site irritation or erythema. - Mild fatigue or malaise. - Elevated liver enzymes (asymptomatic).

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions. - Thromboembolic events including deep‑vein thrombosis or pulmonary embolism. - Development of neutralizing inhibitors (antibodies) against the infused factors. - Hemolysis or renal impairment. - Severe bleeding due to uncontrolled inhibitor formation. - Disseminated intravascular coagulation (rare).

What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Precautions for Octaplex include careful assessment and monitoring before and during therapy.

Allergy assessment: verify no known hypersensitivity to any human plasma‑derived component. Bleeding risk: monitor clinical signs of uncontrolled hemorrhage and factor activity levels. Thrombotic risk: avoid use in patients with active thrombosis or high thrombotic propensity. Pregnancy and lactation: prescribe only when the expected benefit justifies potential risk. Concomitant anticoagulants: adjust dosing and closely monitor coagulation parameters. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?

Octaplex may interact with other agents that affect hemostasis.

Major Interactions (Avoid): - Concurrent use of pro‑coagulant agents (e.g., activated prothrombin complex concentrates) may increase thrombosis risk. - High‑dose vitamin K antagonists can diminish the efficacy of supplied factors. - Heparin co‑administration may potentiate bleeding.

Moderate Interactions (Monitor Closely): - Immunosuppressive drugs may influence inhibitor development; monitor factor activity. - Renal impairment can affect clearance of certain plasma proteins; adjust monitoring frequency. - Antifibrinolytics (e.g., tranexamic acid) should be used with caution in patients at high thrombotic risk.

Frequently asked questions

What is Octaplex used for?+
Octaplex is a sterile intravenous concentrate that contains a combination of human coagulation factors, including factor IX, factor VII, factor X, protein C and protein S. It is used to replace deficient clotting proteins in patients with inherited or acquired bleeding disorders such as hemophilia B, congenital protein C or S deficiency, and other multiple factor deficiencies, helping to achieve normal hemostasis.
How does the active ingredient in Octaplex work?+
The active ingredients are exogenous human coagulation proteins that become part of the patient’s clotting cascade. Once infused, each factor binds to its specific site on activated platelets or endothelial surfaces, restoring the enzymatic steps that convert pro‑thrombin to thrombin and ultimately generate fibrin. This re‑establishes the physiological pathway needed for stable clot formation.
What is the usual dose of Octaplex?+
Dosing of Octaplex is individualized. The prescribing clinician determines the amount based on the patient’s specific factor deficiency, severity of bleeding, body weight, and target plasma activity levels. Doses are calculated to achieve therapeutic factor concentrations and are adjusted according to clinical response and laboratory monitoring.
Is Octaplex safe in pregnancy or breastfeeding?+
Data on the use of Octaplex during pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should discuss the uncertainties and consider alternative therapies when appropriate.
How do I order Octaplex from GNH USA?+
To order Octaplex, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including cold‑chain logistics if needed) and any required import documentation.
How does Octaplex compare with other factor replacement products?+
Octaplex is a plasma‑derived, multi‑factor concentrate, whereas many alternatives are single‑factor recombinant products. The multi‑factor composition can be advantageous for patients with combined deficiencies, reducing the need for multiple separate infusions. However, recombinant single‑factor products may carry a lower risk of viral transmission and can be more precisely dosed for isolated deficiencies.
What are the storage and handling requirements for Octaplex?+
Octaplex must be stored refrigerated at 2‑8 °C. It should be kept in its original container, protected from light, and must not be frozen or shaken. Before use, the product is reconstituted according to the manufacturer’s instructions and administered promptly to maintain stability.
How is Octaplex administered?+
Octaplex is administered by intravenous infusion under medical supervision. After reconstitution, the solution is infused slowly, typically through a peripheral or central line, with vital signs monitored throughout the infusion. The rate and total volume are adjusted based on the prescribed dose and the patient’s clinical condition.
What are the most serious risks associated with Octaplex?+
The most serious risks include severe allergic reactions such as anaphylaxis, thromboembolic events (e.g., deep‑vein thrombosis or pulmonary embolism), and the development of neutralizing inhibitors that render the infused factors ineffective. Prompt recognition and management of these events are essential.
Who should not use Octaplex?+
Octaplex is contraindicated in individuals with a known hypersensitivity to any human plasma‑derived component of the product. It should also be avoided in patients with active, uncontrolled thrombosis or those in whom the risk of thrombosis outweighs the benefit of factor replacement. Clinical judgment is required for all other cases.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F
Route
Intravenous Use
Manufacturer
Jana Pharm D.O.O.
Origin
EU